SGLT2 inhibitors did not reduce MACE and heart failure hospitalization compared to DPP4 inhibitors for primary heart disease prevention.
The median patient age was 67 years, and the median diabetes duration was 8.5 years. The researchers included variables such as age, sex, race, body mass index, blood pressure, laboratory values like hemoglobin A1c, and history of prior illnesses in the statistical analysis.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Daily_Record - 🏆 9. / 89 Read more »
Source: Daily_Record - 🏆 9. / 89 Read more »